No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
- 1 May 2016
- journal article
- review article
- Published by Elsevier in Gynecologic Oncology
- Vol. 141 (2) , 386-401
Abstract
No abstract availableKeywords
Funding Information
- European Commission's Seventh Framework Programme (223175, HEALTH-F2-2009-223175)
- Ovarian Cancer Research Fund (PPD/RPCI.07)
- US National Cancer Institute (U19-CA148112)
- Wellcome Trust (076113)
- National Health and Medical Research Council
- Deutsche Krebshilfe
- American Cancer Society (CRTG-00-196-01-CCE)
- California Cancer Research Program (00-01389V-20170, N01-CN25403, 2II0200)
- Canadian Institutes for Health Research
- Cancer Council Victoria
- Cancer Council Queensland
- Cancer Council New South Wales
- Cancer Council South Australia
- Cancer Council Tasmania
- Cancer Foundation of Western Australia
- Cancer Institute of New Jersey
- Cancer Research UK (C490/A6187, C490/A10119, C490/A10124, C536/A13086, C536/A6689)
- Celma Mastry Ovarian Cancer Foundation
- Danish Cancer Society (94-222-52)
- University of Erlangen-Nuremberg
- Eve Appeal
- Helsinki University Central Hospital Research Fund
- Imperial Experimental Cancer Research Centre (C1312/A15589)
- Ovarian Cancer Research Fund
- Nationaal Kankerplan of Belgium
- L & S Milken Foundation
- Polish Ministry of Science and Higher Education (4 PO5C 028 14, 2 PO5A 068 27)
- Roswell Park Cancer Institute Alliance Foundation
- US National Cancer Institute (K07-CA095666, K07-CA143047, K22-CA138563, N01-CN55424, N01-PC067010, N01-PC035137, P01-CA017054, P01-CA087696, P30-CA15083, P50-CA105009, P50-CA136393, R01-CA014089, R01-CA016056, R01-CA017054, R01-CA049449, R01-CA050385, R01-CA054419, R01-CA058598, R01-CA058860, R01-CA061107, R01-CA061132, R01-CA063678, R01-CA063682, R01-CA064277, R01-CA067262, R01-CA071766, R01-CA076016, R01-CA080978, R01-CA087538, R01-CA092044, R01-095023, R01-CA106414, R01-CA122443, R01-CA112523, R01-CA114343, R01-CA126841, R01-CA149429, R01CA83918, R03-CA113148, R03-CA115195, R37-CA070867, R37-CA70867, U01-CA069417, U01-CA071966)
- US Army Medical Research and Material Command (DAMD17-98-1-8659, DAMD17-01-1-0729, DAMD17-02-1-0666, DAMD17-02-1-0669, W81XWH-07-0449)
- National Health and Medical Research Council of Australia (199600, 400281)
- German Federal Ministry of Education and Research of Germany Programme of Clinical Biomedical Research
- University of Ulm (01 GB 9401)
- Minnesota Ovarian Cancer Alliance
- Mayo Foundation
- Fred C. and Katherine B. Andersen Foundation
- Lon V. Smith Foundation (LVS-39420)
- Oak Foundation
- OHSU Foundation
- Mermaid I project
- Rudolf-Bartling Foundation
- UK National Institute for Health Research Biomedical Research Centres
- National Cancer Institute
- Research Council of Lithuania
- LSC (10.0010.08)
- ESF
- Liepaja's municipal council
- Breast Cancer Research Foundation
- Cancer Association of South Africa (CANSA)
- Neye Foundation
- Spanish Association Against Cancer (RTICC 06/0020/1060, FISPI08/1120)
- Mutua Madrileña Foundation (SAF2010-20493)
- National Cancer Institute (RC4CA153828)
- National Institutes of Health
- Fondazione IRCCS Istituto Nazionale Tumori
- Cancer Research — UK (C12292/A11174, C1287/A10118)
- NHMRC
- European Social Fund — ESF
- General Secretariat for Research & Technology
- European Social Fund Plus
- DKFZ
- Cancer Research UK (C1287/A10118, C1287/A11990)
- NIHR
- NIHR
- Cancer Research UK (C5047/A8385)
- University of Kansas Cancer Center (P30 CA168524)
- Kansas Bioscience Authority Eminent Scholar Program (5U01CA113916, R01CA140323)
- German Cancer Aid (109076)
- Center for Molecular Medicine Cologne (CMMC)
- Ligue national contre le cancer
- Canadian Institutes of Health Research
- National Cancer Institute (CA 27469, CA 37517, CA 101165)
- NCI
- ISCIII (Spain) (RD12/00369/0006, 12/00539)
- European Regional Development FEDER
- Research Council of Finland (132473)
- Finnish Cancer Society
- Sigrid Juselius Foundation
- Dutch Cancer Society (NKI1998-1854, NKI2004-3088, NKI2007-3756)
- NWO (91109024)
- Pink Ribbon (110005)
- BBMRI (CP46/NWO)
- Hungarian Research Grant (KTIA-OTKA CK-80745)
- Asociación Española Contra el Cáncer, Spanish Health Research Fund
- Carlos III Health Institute
- Catalan Health Institute and Autonomous Government of Catalonia (RD06/0020/1051, RD12/0036/008, PI10/01422, PI10/00748, PI13/00285, 2009SGR290)
- Polish Foundation of Science
- Icelandic Association
- Landspitali University Hospital Research Fund
- Canadian Institutes of Health Research
- Canadian Breast Cancer Research Alliance (019511)
- Ministry of Economic Development, Innovation and Export Trade (PSR-SIIRI-701)
- Ministero della Salute
- Istituto Oncologico Veneto
- National Breast Cancer Foundation
- National Health and Medical Research Council (NHMRC)
- Queensland Cancer Fund
- Cancer Councils of New South Wales, Victoria, Tasmania and South Australia
- Cancer Foundation of Western Australia
- NIH (CA128978)
- NCI Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201)
- U.S. Department of Defence (W81XWH-10-1-0341)
- Breast Cancer Research Foundation
- European Regional Development Fund
- State Budget of the Czech Republic (CZ.1.05/2.1.00/03.0101)
- MH CZ — DRO (00209805)
- Breast Cancer Research Foundation
- Niehaus Family Genetics Research Fund
- STARR Cancer Consortium Grants
- US National Cancer Institute
- NIH
- Westat, Inc., Rockville, MD (NO2-CP-11019-50, N02-CP-65504)
- Israel Cancer Association
- Breast Cancer Research Foundation (BCRF)
- Russian Federation for Basic Research (11-04-00227, 12-04-00928, 12-04-01490)
- Federal Agency for Science and Innovations, Russia (02.740.11.0780)
- Ohio State University Comprehensive Cancer Center
- ITT (Istituto Toscano Tumori)
- Israel Cancer Association
- Israeli Inherited breast cancer consortium
- Swedish Cancer Society
- NCI (CA125183, R01 CA142996, U01 CA161032)
- Ralph and Marion Falk Medical Research Trust
- Entertainment Industry Fund National Women's Cancer Research Alliance
- Breast Cancer Research Foundation
- CRUK
- American Cancer Society (SIOP-06-258-01-COUN)
- European Community's Seventh Framework Programme (223175, HEALTH-F2-2009-223175)
- Canadian Institutes of Health Research
- Ministry of Economic Development, Innovation and Export Trade of Quebec (PSR-SIIRI-701)
- CR-UK (C1287/A10118, C1287/A12014)
- European Union COST (BM0606)
- United States National Cancer Institute
- National Institutes of Health (NIH) (RFA-CA-06-503)
- Breast Cancer Family Registry (BCFR)
- Cancer Care Ontario (U01 CA69467)
- Northern California Cancer Center (U01 CA69417)
- University of Melbourne (U01 CA69638)
- National Health and Medical Research Council of Australia
- New South Wales Cancer Council
- Victorian Health Promotion Foundation (Australia)
- Victorian Breast Cancer Research Consortium
- Dutch Cancer Society (NKI 2007-3839, 2009 4363)
- Dutch government (NWO 184.021.007)
- Dutch National Genomics Initiative
- University Hospital of Erlangen
- Cancer Research UK
- NHS
- National Cancer Research Network
- NIHR Comprehensive Biomedical Research Centre
- Oxford Biomedical Research Centre
- Dietmar-Hopp Foundation
- Helmholtz Society
- German Cancer Research Center (DKFZ)
- Fondation de France
- Institut National du Cancer (INCa)
- Ligue Nationale Contre le Cancer
- Ligue contre le Cancer Grand Ouest
- Agence Nationale de Sécurité Sanitaire (ANSES)
- Agence Nationale de la Recherche (ANR)
- Genome Spain Foundation
- Red Temática de Investigación Cooperativa en Cáncer
- Asociación Española Contra el Cáncer
- Fondo de Investigación Sanitario (PI11/00923, PI081120)
- Instituto de Salud Carlos III
- California Breast Cancer Act of 1993
- National Institutes of Health (R01 CA77398)
- Lon V Smith Foundation (LVS39420)
- California Breast Cancer Research Fund (97-10500)
- California Department of Public Health
- Baden Württemberg Ministry of Science, Research and Arts
- German Cancer Aid
- Federal Ministry of Education and Research (BMBF) Germany (01KW9975/5, 01KW9976/8, 01KW9977/0, 01KW0114)
- Robert Bosch Foundation
- Deutsches Krebsforschungszentrum (DKFZ), Heidelberg
- Institute for Prevention and Occupational Medicine of the German Social Accident Insurance
- Institute of the Ruhr University Bochum (IPA)
- Department of Internal Medicine, Evangelische Kliniken Bonn gGmbH, Johanniter Krankenhaus, Bonn, Germany
- Helsinki University Central Hospital Research Fund
- Research Council of Finland (132473)
- Finnish Cancer Society
- The Nordic Cancer Union
- Sigrid Juselius Foundation
- Friends of Hannover Medical School
- Rudolf Bartling Foundation
- German Federal Ministry of Research and Education (RUS08/017)
- Swedish Cancer Society
- Gustav V Jubilee foundation
- Bert von Kantzow foundation
- Kuopio University Hospital
- Cancer Fund of North Savo
- Finnish Cancer Organizations
- Research Council of Finland
- University of Eastern Finland
- National Breast Cancer Foundation
- NHMRC
- Queensland Cancer Fund
- Cancer Councils of New South Wales, Victoria, Tasmania and South Australia
- Cancer Foundation of Western Australia
- NHMRC (145684, 288704, 454508)
- United States Army Medical Research and Materiel Command (DAMD17-01-1-0729)
- Cancer Council Victoria
- Queensland Cancer Fund
- Cancer Council New South Wales
- Cancer Council South Australia
- The Cancer Foundation of Western Australia
- Cancer Council Tasmania
- National Health and Medical Research Council of Australia (400413, 400281, 199600)
- NHMRC
- FWO
- Deutsche Krebshilfe (70-2892-BR I)
- Hamburg Cancer Society
- German Cancer Research Center
- Federal Ministry of Education and Research (BMBF) Germany (01KH0402)
- Italian association for cancer research (AIRC)
- NIH (CA122340, CA128978)
- NIH Specialized Program of Research Excellence (SPORE) in Breast Cancer (CA116201)
- Breast Cancer Research Foundation
- Komen Race for the Cure
- VicHealth
- Cancer Council Victoria
- Australian NHMRC (209057, 251553, 504711)
- Cancer Council Victoria
- NIH (CA63464, CA54281, CA098758, CA132839)
- Canadian Institutes of Health Research (CRN-87521)
- Ministry of Economic Development, Innovation and Export Trade (PSR-SIIRI-701)
- Norwegian Research Council (155218/V40, 175240/S10)
- NIH (R01CA100374)
- NIH (CA87969)
- Finnish cancer foundation
- Research Council of Finland
- University of Oulu
- Oulu University Hospital
- Dutch Cancer Society (RUL 1997-1505)
- Biobanking and Biomolecular Resources Research Infrastructure (BBMRI-NL CP16)
- National Cancer Institute
- Department of Health and Human Services, USA
- Märit and Hans Rausings Initiative Against Breast Cancer
- Dutch Cancer Society (DDHK 2004-3124, DDHK 2009-4318)
- Agency for Science, Technology and Research of Singapore (A*STAR)
- US National Institute of Health (NIH)
- Susan G. Komen Breast Cancer Foundation
- Yorkshire Cancer Research (S295, S299, S305PA)
- Cancer Research UK (C490/A11021, C490/A10124)
- DKFZ
- Polish Foundation of Science
- Breakthrough Breast Cancer
- Institute of Cancer Research (ICR)
- NHS
- Breakthrough Breast Cancer
- Institute of Cancer Research
This publication has 39 references indexed in Scilit:
- An integrated map of genetic variation from 1,092 human genomesNature, 2012
- A polymorphism in a let‐7 microRNA binding site of KRAS in women with endometriosisEMBO Molecular Medicine, 2012
- A KRAS variant is a biomarker of poor outcome, platinum chemotherapy resistance and a potential target for therapy in ovarian cancerOncogene, 2011
- Polygenic susceptibility to prostate and breast cancer: implications for personalised screeningBritish Journal of Cancer, 2011
- A 3′-untranslated region KRAS variant and triple-negative breast cancer: a case-control and genetic analysisThe Lancet Oncology, 2011
- Current misconception 3: that subgroup-specific trial mortality results often provide a good basis for individualising patient careBritish Journal of Cancer, 2011
- A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24Nature Genetics, 2010
- KRAS mutation, KRAS–LCS6 polymorphism, and non-small cell lung cancerLung Cancer, 2010
- Principal components analysis corrects for stratification in genome-wide association studiesNature Genetics, 2006
- Oncomirs — microRNAs with a role in cancerNature Reviews Cancer, 2006